SCHEMBL18763596

SCHEMBL18763596

CC(C)(C)c1ccc(O)c(-c2ccc(O)c(C(C)(C)C)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
ALOX15 P16050 3/20 0.52
HSD17B10 Q99714 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
HPGD P15428 1/20 0.52
LMNA P02545 2/20 0.50
TYR P14679 2/20 0.50
NR1I2 O75469 1/20 0.50
CYP2C9 P11712 1/20 0.50
MIF P14174 1/20 0.50
HTT P42858 1/20 0.50
NFE2L2 Q16236 1/20 0.50
MAPT P10636 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
GAA P10253 1/20 0.47
PKM P14618 1/20 0.47
RECQL P46063 1/20 0.47
RARB P10826 1/20 0.45
RARG P13631 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8707369 0.83 ALDH1A1 (0.55) ALDH1A1ALOX15HSD17B10TDP1HPGD
Potassium SCHEMBL30621340 0.83 ALDH1A1 (0.61) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL29364103 0.82 ALDH1A1 (0.67) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL109921 0.82 ALDH1A1 (0.67) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL30621339 0.81 ALDH1A1 (0.64) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL29851227 0.81 ALDH1A1 (0.64) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL3859151 0.81 ALDH1A1 (0.64) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL30621342 0.81 ALDH1A1 (0.64) ALDH1A1ALOX15HSD17B10TDP1HPGD
Hydrochloric Acid SCHEMBL4359705 0.81 ALDH1A1 (0.64) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL28420832 0.81 ALDH1A1 (0.64) ALDH1A1ALOX15HSD17B10TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108430463-B Improved synthesis of honokiol 高露洁-棕榄公司 2021-01-29 CN disclosed
EP-3364957-B1 IMPROVED SYNTHESIS OF HONOKIOL COLGATE PALMOLIVE CO (US) 2020-12-09 EP disclosed
EP-3364957-A1 IMPROVED SYNTHESIS OF HONOKIOL Colgate-Palmolive Company (US) 2018-08-29 EP disclosed
US-10053406-B2 Synthesis of honokiol COLGATE-PALMOLIVE COMPANY (US) 2018-08-21 US disclosed
US-20170113989-A1 SYNTHESIS OF HONOKIOL COLGATE-PALMOLIVE COMPANY 2017-04-27 US disclosed
WO-2017070568-A1 IMPROVED SYNTHESIS OF HONOKIOL COLGATE-PALMOLIVE COMPANY (US) 2017-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170113989-A1 SYNTHESIS OF HONOKIOL UGT2B7, UGT1A7, DHCR7 ALDH1A1 276/4885ALOX15 323/4885HSD17B10 377/4885
US-10053406-B2 Synthesis of honokiol UGT2B7, UGT1A7, DHCR7 ALDH1A1 276/4885ALOX15 323/4885HSD17B10 377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.